Clinical trials
Recruiting Multiple Myeloma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 6 |
| AstraZeneca | 4 |
| Pfizer | 4 |
| AbbVie | 3 |
| European Myeloma Network B.V. | 3 |
| Genentech, Inc. | 3 |
| Regeneron Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 40 |
| Recurrence | 6 |
| Neoplasms | 3 |
| Smoldering Multiple Myeloma | 2 |
| Blood Protein Disorders | 1 |
| Disease | 1 |
| Hematologic Diseases | 1 |
| Hemostatic Disorders | 1 |
| Immune System Diseases | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.